AP480A - 3-Substituted indole 2-carboxylic acid derivatives. - Google Patents

3-Substituted indole 2-carboxylic acid derivatives. Download PDF

Info

Publication number
AP480A
AP480A APAP/P/1993/000524A AP9300524A AP480A AP 480 A AP480 A AP 480A AP 9300524 A AP9300524 A AP 9300524A AP 480 A AP480 A AP 480A
Authority
AP
ARIPO
Prior art keywords
compound
group
dichloroindole
formula
ethenyl
Prior art date
Application number
APAP/P/1993/000524A
Other languages
English (en)
Other versions
AP9300524A0 (en
Inventor
Alfredo Cugola
Giovannie Gaviraghi
Simone Giacobbe
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of AP9300524A0 publication Critical patent/AP9300524A0/xx
Application granted granted Critical
Publication of AP480A publication Critical patent/AP480A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
APAP/P/1993/000524A 1992-04-16 1993-04-16 3-Substituted indole 2-carboxylic acid derivatives. AP480A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929208492A GB9208492D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
AP9300524A0 AP9300524A0 (en) 1993-04-30
AP480A true AP480A (en) 1996-03-22

Family

ID=10714220

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1993/000524A AP480A (en) 1992-04-16 1993-04-16 3-Substituted indole 2-carboxylic acid derivatives.

Country Status (41)

Country Link
US (4) US5373018A (de)
EP (1) EP0568136A1 (de)
JP (2) JPH0649027A (de)
KR (1) KR100264114B1 (de)
CN (1) CN1042331C (de)
AP (1) AP480A (de)
AT (1) AT403917B (de)
AU (1) AU666927B2 (de)
BE (1) BE1006343A5 (de)
BG (1) BG62136B1 (de)
BR (1) BR1100323A (de)
CA (3) CA2094076A1 (de)
CH (1) CH685630A5 (de)
CY (1) CY2038B1 (de)
CZ (1) CZ285799B6 (de)
DK (1) DK169890B1 (de)
ES (1) ES2105924B1 (de)
FI (1) FI106198B (de)
FR (1) FR2690919B1 (de)
GB (2) GB9208492D0 (de)
GE (1) GEP19991704B (de)
GR (1) GR1001619B (de)
HK (1) HK95797A (de)
HU (2) HU217964B (de)
IL (1) IL105412A (de)
IS (1) IS3994A (de)
IT (1) IT1265325B1 (de)
LU (1) LU88248A1 (de)
MX (1) MX9302195A (de)
MY (1) MY112232A (de)
NO (1) NO301879B1 (de)
NZ (1) NZ247413A (de)
OA (1) OA10103A (de)
PL (1) PL176451B1 (de)
RO (1) RO113242B1 (de)
RU (1) RU2129544C1 (de)
SE (1) SE504336C2 (de)
SK (1) SK281941B6 (de)
TW (1) TW224457B (de)
WO (1) WO1993021153A1 (de)
ZA (1) ZA932642B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
CN1051302C (zh) * 1993-05-27 2000-04-12 默里尔药物公司 3－(吲哚－3－基)丙烯酸衍生物及其用作nmda拮抗剂
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
TW280819B (de) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
GB9504361D0 (en) * 1995-03-04 1995-04-26 Glaxo Spa Heterocyclic compounds
AU4416197A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Positive ampa receptor modulation to enhance brain neurotrophic factor expression
KR20000048715A (ko) * 1996-09-30 2000-07-25 게리 디. 스트리트, 스티븐 엘. 네스비트 Ｎｍｄａ (ｎ-메틸-ｄ-아스파르테이트) 길항제
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
TR200002771T2 (tr) * 1998-03-26 2001-02-21 Fujisawa Pharmaceutical Co.,Ltd. Devamlı salımı olan preparatlar
NZ523812A (en) * 2000-07-31 2004-07-30 Dainippon Pharmaceutical Co Medicaments containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient for treating dementia, dsmnesia, learning deficit and higher brain dysfunction
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
WO2003049702A2 (en) * 2001-12-10 2003-06-19 Amgen Inc. Vanilloid receptor ligands and their use in treatments
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
DE10306202A1 (de) 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
EP1636240A1 (de) * 2003-06-05 2006-03-22 Pfizer Products Inc. Beta-lactamasehemmer prodrug
RU2247563C1 (ru) * 2003-06-16 2005-03-10 Пятигорская государственная фармацевтическая академия Способ получения твердой лекарственной формы, содержащей глюкозамина гидрохлорид
WO2005051919A1 (en) * 2003-11-26 2005-06-09 Pfizer Products Inc. Aminopyrazole derivatives as gsk-3 inhibitors
PL380887A1 (pl) * 2003-12-29 2007-04-02 Sepracor Inc. Pirolowe i pirazolowe inhibitory DAAO
RU2281755C2 (ru) * 2004-04-19 2006-08-20 Пятигорская государственная фармацевтическая академия Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для ректального применения
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
CA2614282A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
AU2007205114B2 (en) 2006-01-06 2012-11-08 Sunovion Pharmaceuticals Inc. Cycloalkylamines as monoamine reuptake inhibitors
CA2636275C (en) * 2006-01-06 2013-02-12 Sepracor Inc. Tetralone-based monoamine reuptake inhibitors
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
EP1942104A1 (de) 2006-12-20 2008-07-09 sanofi-aventis Heteroarylcyclopropancarbonsäureamide und deren pharmazeutische Verwendung
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
US20090099248A1 (en) * 2007-01-18 2009-04-16 Sepracor Inc. Inhibitors of d-amino acid oxidase
AU2008259841B2 (en) 2007-05-31 2015-02-05 Sunovion Pharmaceuticals Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
WO2009151498A2 (en) * 2008-03-28 2009-12-17 Forest Laboratories Holdings Limited Memantine formulations
US20100120740A1 (en) * 2008-08-07 2010-05-13 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
EP2407454A4 (de) * 2009-03-10 2012-05-30 Santen Pharmaceutical Co Ltd Prophylaktikum oder therapeutikum für sehnerverkrankungen mit 4,6-dichlor-1h-indol-2-carbonsäure und derivat oder salz daraus als wirkstoff
US20110034434A1 (en) * 2009-08-07 2011-02-10 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
SG11201607166XA (en) 2014-04-30 2016-09-29 Yufeng Jane Tseng Use of known compounds as d-amino acid oxidase inhibitors
AU2017326359B2 (en) 2016-09-14 2021-02-04 National Chiao Tung University Novel substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors
MX393950B (es) 2017-06-12 2025-03-24 Glytech Llc Composicion y metodo para el tratamiento de la depresion y psicosis en humanos
CN112707874A (zh) * 2020-12-29 2021-04-27 广东中科药物研究有限公司 一种抗病毒化合物及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3010971A (en) * 1960-08-04 1961-11-28 Smith Kline French Lab Cyclopropylamine derivatives and processes for their preparation
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
EP0396124A2 (de) * 1989-05-05 1990-11-07 G.D. Searle & Co. Indol-2-carboxylate enthaltende Zusammensetzungen zur Behandlung von Störungen des Zentralnervensystems

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK500285A (da) * 1984-11-02 1986-05-03 Glaxo Group Ltd Cephalosporinantibiotika
ES2088011T3 (es) * 1990-07-16 1996-08-01 Merrell Pharma Inc Antagonistas de aminoacidos excitadores.
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3010971A (en) * 1960-08-04 1961-11-28 Smith Kline French Lab Cyclopropylamine derivatives and processes for their preparation
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
EP0396124A2 (de) * 1989-05-05 1990-11-07 G.D. Searle & Co. Indol-2-carboxylate enthaltende Zusammensetzungen zur Behandlung von Störungen des Zentralnervensystems

Also Published As

Publication number Publication date
HUT70526A (en) 1995-10-30
MY112232A (en) 2001-05-31
FI106198B (fi) 2000-12-15
BR1100323A (pt) 2000-06-27
CN1042331C (zh) 1999-03-03
AU3692393A (en) 1993-10-21
ES2105924A1 (es) 1997-10-16
TW224457B (de) 1994-06-01
RO113242B1 (ro) 1998-05-29
AP9300524A0 (en) 1993-04-30
AT403917B (de) 1998-06-25
HK95797A (en) 1997-08-08
IL105412A (en) 1998-02-22
GB2266091A (en) 1993-10-20
NO943913D0 (no) 1994-10-14
GB2266091B (en) 1995-08-09
SK281941B6 (sk) 2001-09-11
ITRM930236A0 (it) 1993-04-15
DK43193D0 (da) 1993-04-15
CZ285799B6 (cs) 1999-11-17
WO1993021153A1 (en) 1993-10-28
SK124194A3 (en) 1995-05-10
KR100264114B1 (ko) 2000-11-01
JPH0649027A (ja) 1994-02-22
IL105412A0 (en) 1993-08-18
EP0568136A1 (de) 1993-11-03
GB9307808D0 (en) 1993-06-02
CZ254394A3 (en) 1995-07-12
CA2094076A1 (en) 1993-10-17
BE1006343A5 (fr) 1994-07-26
IT1265325B1 (it) 1996-10-31
BG62136B1 (bg) 1999-03-31
RU2129544C1 (ru) 1999-04-27
HU217964B (hu) 2000-05-28
NO301879B1 (no) 1997-12-22
GR1001619B (el) 1994-07-29
FI944800L (fi) 1994-10-12
US5510367A (en) 1996-04-23
NO943913L (no) 1994-12-14
IS3994A (is) 1993-10-17
ITRM930236A1 (it) 1994-10-15
CY2038B1 (en) 1998-04-30
GEP19991704B (en) 1999-08-05
SE9301241D0 (sv) 1993-04-15
ATA75293A (de) 1997-11-15
DK169890B1 (da) 1995-03-27
SE9301241L (sv) 1993-10-17
NZ247413A (en) 1995-12-21
JPH07505407A (ja) 1995-06-15
RU94045915A (ru) 1996-09-10
FI944800A0 (fi) 1994-10-12
ZA932642B (en) 1994-01-10
HU211826A9 (en) 1995-12-28
CA2094075A1 (en) 1993-10-17
DK43193A (da) 1993-10-17
ES2105924B1 (es) 1998-07-01
CA2094073A1 (en) 1993-10-17
BG99111A (bg) 1995-05-31
OA10103A (en) 1996-12-18
FR2690919A1 (fr) 1993-11-12
PL176451B1 (pl) 1999-05-31
US5374648A (en) 1994-12-20
US5374649A (en) 1994-12-20
MX9302195A (es) 1994-03-31
SE504336C2 (sv) 1997-01-13
AU666927B2 (en) 1996-02-29
LU88248A1 (fr) 1994-03-01
CN1085212A (zh) 1994-04-13
HU9402975D0 (en) 1995-02-28
US5373018A (en) 1994-12-13
FR2690919B1 (fr) 1995-05-05
CH685630A5 (fr) 1995-08-31
GB9208492D0 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
AP480A (en) 3-Substituted indole 2-carboxylic acid derivatives.
US5686461A (en) Indole derivatives
US5962496A (en) Indole derivatives as NMDA antagonists
AP877A (en) Tetrahydroquinoline derivatives as EAA antagonists.
US5977136A (en) Tetrahydroquinolines as NMDA antagonists
KR19980702735A (ko) Ｅａａ 길항제로서의 인돌 유도체
EP0971896A1 (de) 2-chinolincarbonsäurederivat und seine verwendung als excitatory amino acids antagonist
WO1995007887A1 (en) Indole derivatives as antagonists of excitatory amino acids
CZ340599A3 (cs) Derivát kyseliny chinolin-2-karboxylové